Las Vegas, NV -- (SBWIRE) -- 09/21/2013 -- PennyStockEarnings Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Tenet Healthcare Corp (NYSE:THC), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) slipped -0.97% and closed at $14.36 in the last trading session with the overall traded volume of 3.22 million shares, more versus the average volume of 969,998 shares. Its 52 weeks high price was $14.90 and suffered lowest price of $4.35 in the same period.
It has market cap of $856.68 million while its total outstanding shares are 59.66 billion. Its stock’s 3 months performance stands at +93.27%. Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States.
Has RPTP Found The Bottom And Ready To Gain Momentum? Find Out Here
Tenet Healthcare Corp (NYSE:THC) declined -1.73% with the closing price of $42.03. The overall volume in the last trading session was 2.24 million shares. Its fifty two week range was $22.86-$49.47. The total market capitalization remained $4.27 billion.
The stock gained +34.15% in this year and reported the increase of +4.50% in the last 5 days. In its share capital, the company has 101.61 million outstanding shares. Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States.
Will THC Get Buyers Even After The Recent Rally? Find Out Here
Orexigen Therapeutics, Inc. (NASDAQ:OREX) decreased -2.31% to close at $6.55 in the last trading session and its total traded volume was 2.87 million shares, beating the average volume of 858,068. The company has market cap of $647.78 million.
The stock has positive year-to-date performance of +29.60% while its quarterly performance remained +8.90%. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Why Should Investors Buy OREX After the Recent Fall? Just Go Here and Find Out
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) gained +2.55% to closed at $11.06 and its overall volume in the last trading session was 3.00 million shares, beating the average volume of 1.20 million. It has market cap of $741.71 million while its total outstanding shares are 67.06 million.
The stock gained +49.06% in this year and reported the increase of +3.95% in the last 5 days. Its 3 months performance stands at -10.66%. Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
For How Long NBIX’s Gloss will Attract Investors? Find out via this report
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)